Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.140 SEK | -3.39% |
|
+2.70% | -37.36% |
Jul. 10 | Nanologica AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 | CI |
Jul. 10 | Nanologica Increases Revenue but Reports Wider Operating Loss | FW |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -12.71 | -16.69 | -24.79 | -32.2 | -33.07 | |||||
Return on Total Capital | -14.53 | -18.45 | -26.92 | -35.57 | -38.27 | |||||
Return On Equity % | -45.13 | -62.02 | -88.54 | -210.94 | -181.76 | |||||
Return on Common Equity | -45.13 | -62.02 | -88.54 | -210.94 | -181.76 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 82.38 | 33.52 | 55.57 | -1.63 | 29.53 | |||||
SG&A Margin | 161.15 | 229.25 | 711.64 | 866.95 | 266.08 | |||||
EBITDA Margin % | -104.65 | -213.31 | -839.06 | -1.26K | -393.71 | |||||
EBITA Margin % | -107.2 | -217.6 | -849.98 | -1.27K | -398.71 | |||||
EBIT Margin % | -109.65 | -221.48 | -859.39 | -1.28K | -401.36 | |||||
Income From Continuing Operations Margin % | -121.07 | -304.01 | -946.71 | -1.61K | -451.43 | |||||
Net Income Margin % | -121.07 | -304.01 | -946.71 | -1.61K | -451.43 | |||||
Net Avail. For Common Margin % | -121.07 | -304.01 | -946.71 | -1.61K | -451.43 | |||||
Normalized Net Income Margin | -78.57 | -154.24 | -593.2 | -871.08 | -281.99 | |||||
Levered Free Cash Flow Margin | -187 | -219.63 | -553.69 | -593.25 | -391.41 | |||||
Unlevered Free Cash Flow Margin | -175.15 | -205.92 | -500.03 | -516.84 | -364.31 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.19 | 0.12 | 0.05 | 0.04 | 0.13 | |||||
Fixed Assets Turnover | 0.59 | 0.5 | 0.24 | 0.25 | 0.96 | |||||
Receivables Turnover (Average Receivables) | 4.6 | 3.58 | 5.32 | 7.52 | 21.24 | |||||
Inventory Turnover (Average Inventory) | 0.77 | 2.8 | 1.45 | 2.29 | 0.57 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 5.7 | 3.92 | 8.63 | 3.25 | 1.65 | |||||
Quick Ratio | 4.34 | 1.01 | 5.47 | 1.06 | 0.73 | |||||
Operating Cash Flow to Current Liabilities | -2.44 | -3.21 | -3.35 | -3.02 | -1.18 | |||||
Days Sales Outstanding (Average Receivables) | 79.54 | 102.05 | 68.62 | 48.55 | 17.23 | |||||
Days Outstanding Inventory (Average Inventory) | 474.69 | 130.26 | 251.92 | 159.25 | 638.01 | |||||
Average Days Payable Outstanding | 221.12 | 160.28 | 801.71 | 199.94 | 82.39 | |||||
Cash Conversion Cycle (Average Days) | 333.11 | 72.03 | -481.16 | 7.86 | 572.85 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 42.99 | 71.31 | 97.45 | -3.55K | 68.77 | |||||
Total Debt / Total Capital | 30.06 | 41.62 | 49.35 | 102.9 | 40.75 | |||||
LT Debt/Equity | 37.78 | 61.42 | 91.95 | -3.52K | 0.38 | |||||
Long-Term Debt / Total Capital | 26.43 | 35.86 | 46.57 | 102.09 | 0.23 | |||||
Total Liabilities / Total Assets | 36.47 | 47.52 | 52.65 | 102.45 | 48.21 | |||||
EBIT / Interest Expense | -5.78 | -10.1 | -10.01 | -10.46 | -9.26 | |||||
EBITDA / Interest Expense | -4.28 | -7.76 | -8.47 | -9.2 | -8.06 | |||||
(EBITDA - Capex) / Interest Expense | -4.71 | -8.01 | -8.79 | -9.51 | -8.1 | |||||
Total Debt / EBITDA | -2.68 | -1.47 | -1.68 | -1.28 | -1 | |||||
Net Debt / EBITDA | 1.88 | -1 | -0.02 | -1.09 | -0.05 | |||||
Total Debt / (EBITDA - Capex) | -2.44 | -1.42 | -1.62 | -1.24 | -1 | |||||
Net Debt / (EBITDA - Capex) | 1.71 | -0.97 | -0.02 | -1.06 | -0.05 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 50.04 | -19.58 | -60.43 | -19.92 | 211.17 | |||||
Gross Profit, 1 Yr. Growth % | 88.65 | -67.28 | -34.4 | -102.34 | -5.75K | |||||
EBITDA, 1 Yr. Growth % | -2.18 | 111.15 | 29.41 | 20.31 | -16.66 | |||||
EBITA, 1 Yr. Growth % | -1.85 | 108.83 | 28.94 | 19.37 | -15.97 | |||||
EBIT, 1 Yr. Growth % | -1.7 | 106.54 | 28.45 | 19.18 | -16.09 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 5.31 | 101.94 | 23.2 | 36.08 | -12.68 | |||||
Net Income, 1 Yr. Growth % | 5.31 | 101.94 | 23.2 | 36.08 | -12.68 | |||||
Normalized Net Income, 1 Yr. Growth % | 10.93 | 94 | 29.49 | 17.6 | -12.42 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -26.74 | 72.32 | 14.88 | 13.03 | -36.28 | |||||
Accounts Receivable, 1 Yr. Growth % | 514.25 | -79.14 | -45.81 | -38.57 | 89.43 | |||||
Inventory, 1 Yr. Growth % | 21.02 | -47.53 | -51.41 | 154.1 | 1K | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 3.74 | -13.08 | -20.51 | -27.48 | -8.62 | |||||
Total Assets, 1 Yr. Growth % | 184.73 | -32.82 | 57.16 | -49.89 | 84.81 | |||||
Tangible Book Value, 1 Yr. Growth % | 2.16K | -45.57 | 44.32 | -104.5 | -2.39K | |||||
Common Equity, 1 Yr. Growth % | 1.62K | -44.5 | 41.79 | -102.59 | -4K | |||||
Cash From Operations, 1 Yr. Growth % | 343.56 | 7.28 | -2.74 | -20.72 | 125.21 | |||||
Capital Expenditures, 1 Yr. Growth % | 301.88 | -46.1 | 97.9 | 9.82 | -85.08 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 147.94 | 0.48 | -13.4 | -14.2 | 68.19 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 144.59 | 1.02 | -17.31 | -17.23 | 75.02 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 68.7 | 9.85 | -43.59 | -43.71 | 57.86 | |||||
Gross Profit, 2 Yr. CAGR % | 211.45 | -21.43 | -53.67 | -87.6 | 15.07 | |||||
EBITDA, 2 Yr. CAGR % | -3.48 | 26.63 | 81.27 | 24.78 | 8.13 | |||||
EBITA, 2 Yr. CAGR % | -3.36 | 26.57 | 79.65 | 24.06 | 8.12 | |||||
EBIT, 2 Yr. CAGR % | -3.07 | 26.37 | 78.06 | 23.73 | 7.88 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 3.09 | 45.83 | 57.73 | 29.48 | 9.01 | |||||
Net Income, 2 Yr. CAGR % | 3.09 | 45.83 | 57.73 | 29.48 | 9.01 | |||||
Normalized Net Income, 2 Yr. CAGR % | 1.49 | 32.34 | 71.81 | 23.4 | 8.84 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -28.11 | 12.36 | 40.7 | 13.95 | -15.13 | |||||
Accounts Receivable, 2 Yr. CAGR % | 175.19 | 13.2 | -66.38 | -42.31 | 7.87 | |||||
Inventory, 2 Yr. CAGR % | 30.62 | -20.31 | -49.51 | 11.11 | 429.03 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 460.99 | -5.04 | -16.88 | -24.07 | -18.59 | |||||
Total Assets, 2 Yr. CAGR % | 106.47 | 38.31 | 2.75 | -11.26 | -3.76 | |||||
Tangible Book Value, 2 Yr. CAGR % | 101.38 | 250.84 | -11.37 | -74.51 | 1.63 | |||||
Common Equity, 2 Yr. CAGR % | 98.02 | 208.79 | -11.29 | -80.82 | 0.65 | |||||
Cash From Operations, 2 Yr. CAGR % | 92.42 | 118.13 | 2.14 | -12.19 | 33.62 | |||||
Capital Expenditures, 2 Yr. CAGR % | - | 47.18 | 3.28 | 47.42 | -59.52 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 134.25 | 53.03 | 0.11 | -13.8 | 32.72 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 141.92 | 52.08 | -1.49 | -17.27 | 34.74 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 56.33 | 31.79 | -21.85 | -36.6 | -0.47 | |||||
Gross Profit, 3 Yr. CAGR % | 28.21 | 46.97 | -26.02 | -82.86 | -4.58 | |||||
EBITDA, 3 Yr. CAGR % | 1.02 | 15.16 | 35.64 | 58.12 | 14.81 | |||||
EBITA, 3 Yr. CAGR % | 1.03 | 15.09 | 35.28 | 56.76 | 14.65 | |||||
EBIT, 3 Yr. CAGR % | 1.26 | 15.13 | 34.84 | 55.76 | 14.34 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 3.37 | 28.99 | 37.86 | 50.16 | 13.55 | |||||
Net Income, 3 Yr. CAGR % | 3.37 | 28.99 | 37.86 | 50.16 | 13.55 | |||||
Normalized Net Income, 3 Yr. CAGR % | 4.68 | 17.59 | 38.64 | 51.41 | 15.33 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -40.23 | -3.79 | 13.19 | 30.79 | -6.12 | |||||
Accounts Receivable, 3 Yr. CAGR % | 53.38 | 16.46 | -11.45 | -58.9 | -14.25 | |||||
Inventory, 3 Yr. CAGR % | -2.23 | -3.62 | -32.43 | -13.47 | 138.69 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 173.14 | 201.31 | -10.5 | -20.57 | -19.24 | |||||
Total Assets, 3 Yr. CAGR % | 78.08 | 42.01 | 44.33 | -19.12 | 13.33 | |||||
Tangible Book Value, 3 Yr. CAGR % | 334.67 | 30.2 | 160.93 | -67.18 | 14.23 | |||||
Common Equity, 3 Yr. CAGR % | 263.32 | 29.59 | 138.23 | -72.67 | 12.83 | |||||
Cash From Operations, 3 Yr. CAGR % | 23.17 | 58.37 | 66.65 | -6.13 | 20.2 | |||||
Capital Expenditures, 3 Yr. CAGR % | 115.48 | - | 62.45 | 5.42 | -31.3 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 24.92 | 73.06 | 32.68 | -4.91 | 15.12 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 23.56 | 76.88 | 30.49 | -7.04 | 14.5 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 14.49 | 27.89 | 3.98 | -6.22 | 3.53 | |||||
Gross Profit, 5 Yr. CAGR % | 13.29 | 6.93 | -14.67 | -45.34 | -11.72 | |||||
EBITDA, 5 Yr. CAGR % | 7.4 | 8.53 | 21.34 | 23.38 | 23.88 | |||||
EBITA, 5 Yr. CAGR % | 7.47 | 8.64 | 21.07 | 22.97 | 23.68 | |||||
EBIT, 5 Yr. CAGR % | 7.53 | 8.72 | 20.96 | 22.8 | 23.33 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 9.21 | 14.82 | 22.41 | 29.18 | 25.5 | |||||
Net Income, 5 Yr. CAGR % | 9.21 | 14.82 | 22.41 | 29.18 | 25.5 | |||||
Normalized Net Income, 5 Yr. CAGR % | 10.23 | 10.74 | 22.47 | 23.81 | 25.85 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -31.86 | -23.67 | -15.82 | 2.95 | 0.88 | |||||
Accounts Receivable, 5 Yr. CAGR % | 59.51 | 5.26 | -16.42 | -12.06 | -4.18 | |||||
Inventory, 5 Yr. CAGR % | - | 15.77 | -24.94 | 2.02 | 53.91 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 83.56 | 71.45 | 69.72 | 73.61 | -13.83 | |||||
Total Assets, 5 Yr. CAGR % | 34.89 | 25.27 | 42.92 | 17.66 | 22.73 | |||||
Tangible Book Value, 5 Yr. CAGR % | 31.31 | 18.62 | 130.11 | -32.19 | 78.95 | |||||
Common Equity, 5 Yr. CAGR % | 30.95 | 18.55 | 106.71 | -39.65 | 68.78 | |||||
Cash From Operations, 5 Yr. CAGR % | 25.45 | 14.93 | 14.29 | 25.09 | 52.55 | |||||
Capital Expenditures, 5 Yr. CAGR % | 18.91 | -3.52 | 60.56 | - | -6.82 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 18.47 | 14.9 | 12.93 | 34.71 | 32.7 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 17.05 | 13.6 | 11.37 | 34.49 | 32.17 |
- Stock Market
- Equities
- NICA Stock
- Financials Nanologica AB
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions